| scholarly article | Q13442814 |
| P50 | author | Silvia Franceschi | Q56417107 |
| Joakim Dillner | Q62918677 | ||
| P2093 | author name string | Matti Lehtinen | |
| Guglielmo Ronco | |||
| Iacopo Baussano | |||
| Fulvio Lazzarato | |||
| P2860 | cites work | Infection transmission and chronic disease models in the study of infection-associated cancers | Q27011403 |
| Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis | Q28084924 | ||
| Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study | Q28245583 | ||
| A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women | Q30052389 | ||
| Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials | Q30970916 | ||
| Role of herd immunity in determining the effect of vaccines against sexually transmitted disease | Q34380787 | ||
| Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach | Q34979497 | ||
| Directly transmitted infections diseases: control by vaccination. | Q52724929 | ||
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. | Q52745312 | ||
| The carcinogenicity of human papillomavirus types reflects viral evolution. | Q53357731 | ||
| Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity | Q57089351 | ||
| A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion | Q58475803 | ||
| Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 | ||
| Third Italian national survey on knowledge, attitudes, and sexual behaviour in relation to HIV/AIDS risk and the role of health education campaigns | Q82766300 | ||
| Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11 | Q85160464 | ||
| Genital transmission of human papillomavirus in recently formed heterosexual couples | Q35463790 | ||
| Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. | Q35677549 | ||
| Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013. | Q36418117 | ||
| Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior | Q36418125 | ||
| Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis | Q36745242 | ||
| Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis. | Q36964366 | ||
| Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections | Q36994715 | ||
| Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis | Q37001336 | ||
| Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes | Q37288157 | ||
| Estimation of the HIV basic reproduction number in rural south west Uganda: 1991-2008. | Q37431327 | ||
| Type-specific human papillomavirus biological features: validated model-based estimates | Q37439328 | ||
| Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study | Q37839810 | ||
| Estimating the basic reproductive rates of Neisseria gonorrhoeae and Chlamydia trachomatis: the implications of acquired immunity | Q37888112 | ||
| Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis | Q38037763 | ||
| Clinical trials of human papillomavirus vaccines and beyond | Q38111962 | ||
| Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis | Q38848935 | ||
| Host immunity and synchronized epidemics of syphilis across the United States | Q39706272 | ||
| Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial | Q41145359 | ||
| Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. | Q42219536 | ||
| Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial | Q42257816 | ||
| Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer | Q43596600 | ||
| Carcinogenic human papillomavirus infection | Q44863515 | ||
| Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. | Q46129985 | ||
| Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial | Q49169372 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 336-344 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study | |
| P478 | volume | 216 |
| Q59360768 | Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs |
| Q90191537 | Diversity of human papillomavirus typing among women population living in rural and remote areas of Brazilian territory |
| Q92089108 | Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions |
| Q104289818 | From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness |
| Q51731914 | Impacts of human papillomavirus vaccination for different populations: A modelling study. |
| Q64069368 | Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach |
| Q92639998 | Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014) |
Search more.